|
METABOLIC ANTIANGINAL DRUGS
Description: By M. MOHSEN IBRAHIM, MD
More details
Selective Heart Rate-Lowering Agents
Description: By M. MOHSEN IBRAHIM, MD
More details
ASPIRIN
Description: By M. MOHSEN IBRAHIM, MD
More details
Thienopyridines: Ticlopidine and Clopidogrel
Description: By M. MOHSEN IBRAHIM, MD
More details
Glycoprotein IIb/IIIa Antagonists
Description: By M. MOHSEN IBRAHIM, MD
More details
Manual of Hypertension
Description: Hypertension is a major public health problem in many parts of the world. It has been identified as the most common, most potent and most universal con-tributor to cardiovascular mortality. The disease carries special importance for a number of reasons.
More details
Pharmacological Therapy of Coronary Disease
Description: By M. MOHSEN IBRAHIM, MD
More details
Importance of Pharmacologic Approach
Description: By M. MOHSEN IBRAHIM, MD
More details
Evaluation of Therapeutic Efficacy
Description: By M. MOHSEN IBRAHIM, MD
More details
Results of Clinical Trials
Description: By M. MOHSEN IBRAHIM, MD
More details
Chronic Stable Angina (Non-Acute CAD)
Description: By M. MOHSEN IBRAHIM, MD
More details
Acute Coronary Syndromes
Description: By M. MOHSEN IBRAHIM, MD
More details
Part II Anti Ischemic Drugs
Description: By M. MOHSEN IBRAHIM, MD
More details
Beta-Adrenergic Blockers (BABs)
Description: By M. MOHSEN IBRAHIM, MD
More details
Calcium Antagonists
Description: By M. MOHSEN IBRAHIM, MD
More details
|
